Dualitas Therapeutics, Inc.
Biotechnology company · South San Francisco, California, United States
Dualitas Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $33 million sold in a notice filed in 2025.
Dualitas Therapeutics at a glance
What does Dualitas Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $32.6 million sold (2025).
Frequently asked questions about Dualitas Therapeutics
Where is Dualitas Therapeutics headquartered?
Dualitas Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Dualitas Therapeutics do?
Dualitas Therapeutics, Inc. is a biotechnology company.
When was Dualitas Therapeutics founded?
The earliest incorporation on record for Dualitas Therapeutics, Inc. is in 2023, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences